149 related articles for article (PubMed ID: 19934567)
41. Head injury is not a risk factor for multiple sclerosis: a prospective cohort study.
Pfleger CC; Koch-Henriksen N; Stenager E; Flachs EM; Johansen C
Mult Scler; 2009 Mar; 15(3):294-8. PubMed ID: 19028828
[TBL] [Abstract][Full Text] [Related]
42. Pediatric multiple sclerosis with primary progressive course--report of a retrospective cohort study in Iran.
Etemadifar M; Afzali P; Tabrizi N; Hosseini SA
Neuropediatrics; 2013 Jun; 44(3):167-70. PubMed ID: 23254570
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics of multiple sclerosis in Lebanon.
Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
[TBL] [Abstract][Full Text] [Related]
44. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.
Debouverie M; Pittion-Vouyovitch S; Louis S; Roederer T; Guillemin F
Mult Scler; 2007 Sep; 13(8):962-7. PubMed ID: 17623734
[TBL] [Abstract][Full Text] [Related]
45. Leprosy profile in Isfahan (A province of Iran).
Asilian A; Faghihi G; Momeni A; Radan MR; Meghdadi M; Shariati F
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):129-30. PubMed ID: 16830657
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain).
Ares B; Prieto JM; Lema M; Dapena D; Arias M; Noya M
Mult Scler; 2007 Mar; 13(2):262-4. PubMed ID: 17439895
[TBL] [Abstract][Full Text] [Related]
47. The Danish Multiple Sclerosis Registry. History, data collection and validity.
Koch-Henriksen N; Rasmussen S; Stenager E; Madsen M
Dan Med Bull; 2001 May; 48(2):91-4. PubMed ID: 11414126
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy.
Montomoli C; Citterio A; Piccolo G; Cioccale R; Ferretti VV; Fratti C; Bergamaschi R; Cosi VE
Neuroepidemiology; 2012; 38(2):100-5. PubMed ID: 22377708
[TBL] [Abstract][Full Text] [Related]
49. Possible increasing risk of multiple sclerosis in Catania, Sicily.
Nicoletti A; Patti F; Lo Fermo S; Sorbello V; Reggio E; Maimone D; Zappia M; Reggio A
Neurology; 2005 Oct; 65(8):1259-63. PubMed ID: 16247054
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of 4 cases with clinical characteristics of myasthenia gravis and multiple sclerosis].
Satoyoshi E; Kinoshita M; Nakazato H; Saku A
Rinsho Shinkeigaku; 1975 Nov; 15(11):888-94. PubMed ID: 1241360
[No Abstract] [Full Text] [Related]
51. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
Gotkine M; Fellig Y; Abramsky O
Neurology; 2006 Sep; 67(5):881-3. PubMed ID: 16966558
[TBL] [Abstract][Full Text] [Related]
52. Interferon causes no myasthenia in a seropositive patient with multiple sclerosis.
Shimizu H; Kataoka H; Kawahara M; Hirano M; Furiya Y; Ueno S
Clin Neurol Neurosurg; 2007 Apr; 109(3):277-8. PubMed ID: 17118531
[TBL] [Abstract][Full Text] [Related]
53. Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan.
Araki S; Uchino M; Kumamoto T
Neuroepidemiology; 1987; 6(3):120-9. PubMed ID: 3658081
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.
Barzegar M; Vaheb S; Mirmosayyeb O; Ashtari F; Afshari-Safavi A; Adibi I; Shaygannejad A; Mazaheri S; Rahimi M; Shaygannejad V
Mult Scler Relat Disord; 2024 Apr; 84():105479. PubMed ID: 38359695
[TBL] [Abstract][Full Text] [Related]
55. Epileptic seizures in multiple sclerosis: a population-based survey in Iran.
Etemadifar M; Abtahi SH; Roomizadeh P
Acta Neurol Belg; 2013 Sep; 113(3):271-8. PubMed ID: 23111776
[TBL] [Abstract][Full Text] [Related]
56. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
57. Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.
Etemadifar M; Nourian SM; Nourian N; Abtahi SH; Sayahi F; Saraf Z; Fereidan-Esfahani M
J Child Neurol; 2016 Jun; 31(7):932-7. PubMed ID: 26979097
[TBL] [Abstract][Full Text] [Related]
58. Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings.
Somer H; Müller K; Kinnunen E
J Neurol Sci; 1989 Jan; 89(1):37-48. PubMed ID: 2926441
[TBL] [Abstract][Full Text] [Related]
59. Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran.
Etemadifar M; Jahanbani-Ardakani H; Ghaffari S; Fereidan-Esfahani M; Changaei H; Aghadoost N; Jahanbani Ardakani A; Moradkhani N
Caspian J Intern Med; 2017; 8(3):172-177. PubMed ID: 28932368
[TBL] [Abstract][Full Text] [Related]
60. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.
Sahraian MA; Khorramnia S; Ebrahim MM; Moinfar Z; Lotfi J; Pakdaman H
Eur Neurol; 2010; 64(6):331-6. PubMed ID: 21071949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
